Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Tattelecom reported for 6 months of 2023 by RAS

8/4/23 TTLK

Block has reported for 6 months of 2023

8/4/23 SQ

Apple reported for 9 months of fiscal year 2023

8/4/23 AAPL

Gilead has reported for 6 months of 2023

8/4/23 GILD

Amazon has reported for 6 months of 2023

8/4/23 AMZN

Moscow Exchange may launch short-term CFAs for cash claims

8/4/23 MOEX

Airbnb reported for 6 months of 2023

8/4/23 ABNB

SPB Exchange will admit 100 more Hong Kong-listed securities to trading by the end of the year

8/4/23 SPBE

Globaltruck reported for 6 months of 2023 by RAS

8/4/23 GTRK

X5 Retail Group takes measures to maintain its listing on the Moscow Exchange

8/3/23 -